JonesTrading Initiates Coverage On Trevi Therapeutics with Buy Rating, Announces Price Target of $7
JonesTrading analyst Sean Kim initiates coverage on Trevi Therapeutics (NASDAQ:TRVI) with a Buy rating and announces Price Target of $7.
Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Gainers
COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 58.4% to $0.1069 in pre-market trading after gaining more than 16% on Tuesday.
Earnings Outlook For Trevi Therapeutics, Inc. – Common Stock
Trevi Therapeutics, Inc. - Common Stock (NASDAQ:TRVI) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement.
Trevi Therapeutics Priced ~14.25M Share Public Offering of Common Stock @$1.93/Share
Trevi Therapeutics, Inc. (Nasdaq: TRVI) today announced the pricing of its underwritten public offering of 14,252,670 shares of its common stock at a public offering price of $1.93 per share, and, to certain investors in lieu of common stock, pre-funded warrants to purchase 14,247,330 shares of common stock at a price of $1.92
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell
• Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Dow Jumps 150 Points; Icosavax Shares Plunge
U.S. stocks turned higher toward the end of trading, with the Dow Jones gaining around 150 points on Wednesday.
Why U.S. Stocks Are Trading Higher, GDP Report And More
U.S. stocks traded higher this morning, with the Dow Jones gaining around 180 points on Wednesday.
34 Stocks Moving In Monday’s Mid-Day Session
Gainers
Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions.